Inactive Instrument

News Meridian Bioscience, Inc.

Equities

VIVO

US5895841014

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Meridian Bioscience, Inc. Drives Democratization of Next-Generation Sequencing with Reagents Enabling Ambient Temperature Shipping and Storage of Sequencing Kits	Apr. 10	CI
Meridian Bioscience, Inc. announced that it has received KRW 128.772575398 billion in funding	Nov. 29	CI
Meridian Bioscience, Inc. announced that it expects to receive KRW 128.772575393 billion in funding	Nov. 21	CI
Meridian Bioscience, Inc. announced that it has received KRW 258.225164381 billion in funding from Columbus Holding Company	23-07-27	CI
Meridian Bioscience Continues Expansion of H. Pylori Diagnostic Testing Solutions with Fda Clearance of Premier Hpsa Flex	23-07-25	CI
Meridian Bioscience Sets a New Sustainability Standard in Diagnostic Assay Development with the Launch of Two New Animal-Free Immunoassay Interference Blockers	23-07-25	AQ
Meridian Bioscience, Inc. announced that it expects to receive KRW 258.225164381 billion in funding	23-06-11	CI
Meridian Bioscience, Inc. Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay	23-04-19	CI
MERIDIAN BIOSCIENCE INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23-02-09	AQ
Meridian Bioscience, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-09	CI
MERIDIAN BIOSCIENCE INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial S (form 8-K)	23-02-01	AQ
SD Biosensor, SJL Partners Acquire Meridian Bioscience	23-01-31	MT
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience	23-01-31	PR
Meridian Bioscience, Inc.(NasdaqGM:VIVO) dropped from NASDAQ Composite Index	23-01-31	CI
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P Healthcare Equipment Select Industry Index	23-01-31	CI
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P 600	23-01-31	CI
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P Composite 1500	23-01-31	CI
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P Global BMI Index	23-01-31	CI
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P TMI Index	23-01-31	CI
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P 1000	23-01-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Meridian Bioscience, Inc.

Equities

VIVO

US5895841014

Summary

Filters